Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

John Brown to chair Cell Therapy Catapult

Will lead new UK centre to support biotech companies involved in cell therapy technology

- PMLiVE

FDA urged to give biosimilar medicines distinct scientific names

Alliance for Safe Biologic Medicines highlights safety concerns if different products have same name

- PMLiVE

Demonstrating value and improving access

In today’s dynamic healthcare market, it’s all about how we can demonstrate value and improve access – it is the art of effective communication and education that will enable success

- PMLiVE

Boehringer launches Facebook game

Syrum aims to teach players about the complexity of medicine development

- PMLiVE

UK hospitals cannot cope with demand says RCP

Report claims acute care on “brink of collapse”

- PMLiVE

Bayer buys Teva animal health unit

Deal valued at $145m

- PMLiVE

Sanofi taps Oncodesign for kinase inhibitor platform

French firms form €130m alliance

- PMLiVE

CLM Brings Supermarket Savvy to Pharma

The technology is there – pharma can now individualise its communications – through the use of closed-loop marketing. It’s all a matter of engaging customer insights. Learn from your experience...

- PMLiVE

Oliver Rausch to lead translational research partnership efforts at NIHR

Has experience at UCB, GSK and Cellzome

- PMLiVE

Interview: Cavan Redmond, WebMD

The new CEO of WebMD talks to PMLiVE about his move from Pfizer

- PMLiVE

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

Eisai launches epilepsy drug Fycompa in UK

CEO of Eisai EMEA Gary Hendler says UK “last free pricing market in Europe”

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links